MolNFT v1 · #186521 · protein
Human retinal variant IMPDH1(546) treated with ATP, imp, NAD+, octamer-centered
7RGM: “Human retinal variant IMPDH1(546) treated with ATP, imp, NAD+, octamer-centered”. Electron microscopy, 3 ligands (ATP, IMP, NAD). MolNFT v1 #186521 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 7RGM
- Type
- protein
- Length
- 3,872 residues
- Chains
- 8
- Method
- electron microscopy
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P20839
- Ligands
- ATP, IMP, NAD
Structure
electron microscopy · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B, C, D, E, F, G, H | — | protein | 484 | — | P20839 |
Ligands and binding sites
- ATP · Adenosine-5'-triphosphate · ligand · 16 copies · chains A, H, B, G, C, F, D, E
- IMP · Inosinic acid · ligand · 8 copies · chains A, B, C, D, E, F, G, H
- NAD · Nicotinamide-adenine-dinucleotide · ligand · 8 copies · chains A, D, B, C, E, H, F, G
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 7RGM · Human retinal variant IMPDH1(546) treated with ATP, imp, NAD+, octamer-centered · the same entry in another collection · chain H against H, TM-score 1.00
- P20839 · AlphaFold monomer V2.0 prediction for inosine-5'-monophosphate dehydrogenase 1 (P20839) · a predicted model of the same protein · chain A against A, TM-score 0.87
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P20839
- Elsewhere: RCSB PDB 7RGM · PDBe 7RGM · UniProt P20839
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.